Qiagen, AstraZeneca Reach CDx Deal for NSCLC | GenomeWeb

NEW YORK (GenomeWeb) – Qiagen today announced a collaborative deal with AstraZeneca to develop a liquid biopsy-based companion diagnostic for the drugmaker's targeted non-small cell lung cancer therapy Iressa (gefitinib).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.